During the past decade, DIM Clinica Privada conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 9 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DIM Clinica Privada" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "CymaBay Therapeutics, Inc." with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Inovio Pharmaceuticals" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DIM Clinica Privada" #1 collaborator was "ARTTIC International Management Services" with 1 trials as a collaborator, "BPLab" with 1 trials as a collaborator, "Federación Argentina de Cardiología FAC" with 1 trials as a collaborator, "Ferrer Internacional S.A." with 1 trials as a collaborator and "Fundacion Clinic per a la Recerca Biomédica" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "DIM Clinica Privada" are "Diabetes Mellitus, Type 2" (3 trials), "Hypertension" (3 trials), "Obesity" (3 trials), "Atrial Fibrillation" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "DIM Clinica Privada" in a lesser frequency.

Most popular intervention types in "DIM Clinica Privada" are "Drug" (19 trials), "Biological" (3 trials), "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Tirzepatide" (4 trials), "Darusentan" (2 trials), "VGX-3100" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "DIM Clinica Privada" are 23 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "DIM Clinica Privada". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in DIM Clinica Privada, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in DIM Clinica Privada, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".